Rayner Newsroom

Find out more about the latest news taking place at Rayner!

Rayner appoints esteemed ophthalmic leaders as strategic advisors and is awarded IDE for trifocal IOLs

Posted on 22/12/2021

DECEMBER 22, 2021 – Worthing, United Kingdom. Rayner, a leading UK-based ophthalmic company focused on optimising visual outcomes for surgeons and their patients, is delighted to announce the appointment of Drs Eric Donnenfeld, Kerry Solomon, Vance Thompson, and Mr Jim Mazzo as strategic advisors to the business, with a specific focus on supporting the expansion

Read more

Rayner acquires Omidria to expand surgical offering in USA and Europe

Posted on 7/12/2021

DECEMBER 02, 2021 – Worthing, United Kingdom. Rayner Surgical Group (‘Rayner’) and Omeros Corporation (‘Omeros’) are delighted to announce the transfer of Omeros’ ophthalmology assets, including OmidriaTM, to Rayner. This will enable the creation of a significant commercial, regulatory and marketing infrastructure in the US, with a broad range of products, including intraocular lenses (IOLs), for cataract surgeons.

Read more

Rayner Receives Third FDA Approval in RayOne IOL Portfolio

Posted on 17/05/2021

New York, USA, May 17, 2021 – RayOne Spheric, a fully-preloaded monofocal IOL, has received FDA approval. This achievement marks Rayner’s third FDA approval in under three years within its expanding RayOne preloaded IOL portfolio. RayOne Spheric joins RayOne Aspheric (FDA approved December 2018) and RayOne EMV, a new non-diffractive IOL solution which achieved FDA

Read more